Enter your login e-mail to the account
Search
- Tyrosine kinase inhibitor sunitinib malate
MUDr. Patrick Palacka, PhD., MPH, MBA
(3/2013, Drugs & drug classes ) - Molecular markers of targeted therapy in oncology malignancies
RNDr. Katarína Hlinková
(2/2010, Review articles ) - Myelofibrosis – diagnosis, management, new treatment options
MUDr. Anna Vallová
(6/2015, Review articles ) - Myelodysplastic syndrome – classification, pathophysiology
prof. MUDr. Elena Tóthová, CSc.
(1/2014, Spectrum ) - FLT3mutácie u pacienta s AML: incidencia, možnosti diagnostiky a vplyv na manažment liečby
MUDr. Eva Mikušková, PhD., RNDr. Renata Lukačková, RNDr. Imrich Hikkel, PhD., Mgr. Michaela Zrubcová
(3/2018, Original articles & case reports ) - Gilteritinib for the treatment of relapsed and/or refractory FLT3-mutated acute myeloid leukemia
MUDr. Juraj Chudej, PhD., MBA, doc. MUDr. Juraj Sokol, PhD., MBA, MUDr. Ľudmila Lineková, MUDr. Monika Péčová, MUDr. Lenka Lisá, PhD.
(2/2023, Review articles ) - Case report of a patient with acute myeloid leukemia on maintenance therapy with gilteritinib after allogeneic transplantation
MUDr. Renáta Pizurová, MUDr. Kristína Mária Beláková, doc. MUDr. Juraj Sokol, PhD., MBA, MUDr. Ladislav Sopko, PhD.
(5/2025, Case reports ) - Treatment of patients with FLT3 positive acute myeloblastic leukemia
MUDr. Firas Farkaš, PhD., doc. MUDr. Martin Mistrík, PhD., prof. MUDr. Angelika Bátorová, PhD.
(6/2019, Review articles )












